BPC-157 Research Guide
A synthetic 15-amino-acid peptide from a gastric protein sequence, sold as BPC-157 5mg and found in the Wolverine, GLOW and KLOW blends. Covers tendon cell and blood vessel research and two systematic reviews.
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide, a chain of 15 amino acids. It is a partial sequence of body protection compound (BPC), a protein reported in human gastric juice (Chang et al., 2011).
We supply BPC-157 5mg on its own. It is also a component of the Wolverine (with TB-500), GLOW (with GHK-Cu and TB-500) and KLOW (with GHK-Cu, TB-500 and KPV) research blends.
Research areas studied
The findings below come from cell, animal and published clinical research. They describe what studies have examined and reported, not effects of any research material.
Tendon cell research
In a study using rat Achilles tendon explants and cultured tendon fibroblasts, BPC-157 increased the outgrowth of fibroblasts from the explants, improved cell survival under hydrogen peroxide stress, and increased fibroblast migration and spreading in a dose-dependent way. It did not directly change cell proliferation. The authors linked these effects to activation of the FAK-paxillin pathway (Chang et al., 2011).
Blood vessel formation models
In the chick chorioallantoic membrane assay and an endothelial tube formation assay, BPC-157 increased vessel density. In rats with hind limb ischemia it was associated with faster recovery of blood flow and more vessels. In human vascular endothelial cells it increased VEGFR2 expression and activated the VEGFR2-Akt-eNOS signaling pathway (Hsieh et al., 2017).
What the systematic reviews found
A 2025 systematic review identified 36 eligible studies, 35 of them preclinical, reporting outcomes in muscle, tendon, ligament and bone injury models. It described a half-life of under 30 minutes in the studies reviewed and found no clinical safety data (Vasireddi et al., 2025). A 2026 systematic review of the human evidence found three small studies with 30 participants in total. All three were judged to be of poor methodological quality, and the overall certainty of evidence was rated very low (Poolton et al., 2026).
Regulatory status
BPC-157 is not an FDA-approved drug (Vasireddi et al., 2025). FDA’s compounding safety page lists it among nominated bulk substances whose nominations were withdrawn, and notes concerns about possible immunogenicity and peptide-related impurities. The authors of the 2026 review concluded that human use outside regulated clinical trials is not supported by the current evidence (Poolton et al., 2026).
Storage and handling
Like most research peptides, BPC-157 is normally supplied for laboratory use as a lyophilized (freeze-dried) powder in a sealed vial. Check the label and the batch COA for the exact form of your lot. Zero Zero Collection recommends keeping vials refrigerated at 2 to 8 ยฐC and protected from light, as stated on every product page. Let a refrigerated vial reach room temperature before opening it so moisture does not condense on the powder.
When a lab reconstitutes lyophilized material, standard practice is to add a sterile diluent such as bacteriostatic water slowly down the inside wall of the vial, then swirl gently rather than shake. The volume depends on the concentration a protocol calls for, so follow your own lab’s validated method. Label the vial with the date, keep reconstituted material refrigerated, and follow your institution’s guidance on how long a solution stays usable.
Quality and COA
Where a certificate of analysis has been published for a product, its product page has a View COA link. Certificates come from independent third-party testing by Freedom Diagnostics and are posted on our Quality page. A COA reports what the testing lab measured for one specific batch, so match the lot number on your vial to the certificate. Our FAQ explains how to read a COA.
BPC-157 FAQ
Does Zero Zero Collection sell BPC-157 on its own?
Yes. BPC-157 5mg is supplied on its own. BPC-157 is also part of the Wolverine 10mg, Wolverine 20mg, GLOW 70mg and KLOW 80mg research blends.
Where does the name BPC-157 come from?
BPC stands for body protection compound, a protein reported in human gastric juice. BPC-157 is a synthetic 15-amino-acid partial sequence of it.
What does the human evidence on BPC-157 look like?
A 2026 systematic review found only three small human studies (30 participants in total), all of poor methodological quality, and rated the certainty of evidence as very low.
Is BPC-157 FDA-approved?
No. It is not an approved drug, and FDA lists it among bulk substances whose compounding nominations were withdrawn.
References
- Chang CH, Tsai WC, Lin MS, et al. (2011). J Appl Physiol. PubMed 21030672
- Hsieh MJ, Liu HT, Wang CN, et al. (2017). J Mol Med (Berl). PubMed 27847966
- Vasireddi N, Hahamyan H, Salata MJ, et al. (2025). HSS J. PubMed 40756949
- Poolton JT, Minett J, Kazmi A (2026). Acta Orthop Belg. PubMed 42885452
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. Accessed October 28, 2026. fda.gov
For research use only. Not for human consumption. This guide summarizes published scientific literature for laboratory research context. It is not medical advice, dosing guidance or a claim of safety or effectiveness for any use in people or animals.